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Renal ischemia contributes to renal damage in rat model of anti-
myeloperoxidase associated necrotizing crescentic glomerulonephritis
(NCGN). E. Brouwer, PA. Kiok, MG. Huitema, J.J. Weening and C.G.M
Kallenberg Depts. of Clinical Immunology and Pathology, Academic Medi-
cal Centre, and University Hospital Groningen, The Netherlands. Human
anti-myeloperoxidase (MPO) associated NCGN is characterized by cres-
cent formation and glomerular and interstitial infiltration with inflamma-
tory cells. Focal fibrinoid necrosis of capillary loops is present at a very
early stage in the development of NCGN, indicating that focal endothelial
cell damage and GBM necrosis, possibly due to focal ischemia, are
prerequisites for the development of NCGN in the presence of anti-MPO
antibodies. In a recently developed model of anti-MPO associated NCGN
we showed that anti-MPO alone is not sufficient for the induction of
NCGN, but that MPO, lytic enzymes, and oxygen radicals need to be
localized along the GBM as well. Since ischemia triggers endothelial cells
to produce oxygen radicals, we tested whether renal ischemia plays a role
in the induction of anti-MPO associated NCGN. Ischemia was induced in
MPO-immunized rats (N = 13) perfused with a lysosomal extract contain-
ing MPO, HLE, and Pr3, by clamping the left renal artery for 20 minutes
after perfusion (group I). The control groups consisted of MPO immu-
nized rats (N = 7) perfused with Pr3, MPO, and HLE which were not
clamped (group II), and control immunized rats (N = 6) perfused with the
lysosomal extract containing MPO, HLE, and Pr3, and clamped for 20
minutes (group III). Rats were sacrificed at 24 hours, 4 days, and 10 days
after perfusion. By lightmicroscopy we found necrosis, crescent formation
and infiltration of inflammatory cells as shown in the table in group I, but
not in groups II and III. MPO, immunoglobulin (Ig), and complement
(C3) deposition and the numbers of infiltrated neutrophils (PMN) and
monocytes (MO) were quantified by immunohistochemistry.
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We conclude that renal ischemia may indeed play a role in the induction
of anti-MPO associated NCGN.
The renal effect of adenosine infusion depends on the route of admin-
istration. R. Fransen and HA. Koomans, Utrecht University Hospita4 Dept.
of Nephrology, Utrecht, The Netherlands. Systemic infusion of adenosine
(ADO) causes anti-diuresis in the rat, whereas intrarenal infusion has
been reported to cause diuresis. These opposite effects have not been
demonstrated within the same animal. Furthermore, the tubular location
of the diuretic effect has not been investigated. A small catheter was
advanced into the left renal artery of male Sprague Dawley rats and saline
with different ADO concentrations was infused at a constant rate. Next,
the catheter was repositioned into the thoracic aorta, above both renal
arteries and, after saline, ADO (50 glmin) was infused.
U-flow 1.d/min GFR mI/mm
Right Left Right Left
Intra-renal ADO
0 g/min 4.8 0.7 5.2 2.4 1.34 0.04 1.32 0.07
5 .tg/min 4.8 0.2 12.5 2.1 1.31 0.06 1,42 0.14
10 Wmin 5.1 0.9 13.7 3,7a 1.34 0.10 1.24 0.12
50 ,.g/min 5.8 1.9 12.5 3.1k 1.34 0.16 1.16 0.06
Aorta ADO
0 g/min 5.1 1.0 5.5 1.5 1.36 0.16 1.17 0.06
50 g/min 2.9 0.3a 3.1 1.oa 0.92 o.ola 0.92 0.04
Data are mean SE; ap < 0.05 vs. infusion of saline without ADO
(ANOVA)
Blood pressure and filtration fraction did not change during the study.
Intrarenal infusion caused diuresis and natriuresis (not shown) without a
change in GFR, suggesting a direct tubular effect. ADO infusion in the
aorta of the same animal resulted in antidiuresis, and a reduction in GFR.
Intrarenal ADO infusion, below 5 sg/min, had no effect on urine flow or
GFR. Thus, it is unlikely that the different response to the administration
routes depends on different ADO concentrations reaching the kidney. To
assess the effect of intra-renal ADO, we performed micropuncture in rats
infused intra-renally with saline or 10 Wmin ADO. Urine flow increased
as in the clearance study. No significant change in absolute or fractional
delivery of water or sodium up to the early distal tubule was observed. We
conclude that the intrarenal administration of ADO increases renal
excretion of water and sodium, probably by a direct tubular effect. This
effect is not located in the proximal tubule or loop of Henle of superficial
tubules. Systemic ADO infusion causes antidiuresis, partly by reducing
GFR.
ATP-induced inhibition of calcium transport in primary cultures of
rabbit cortical collecting system is mediated by P2.purinergic receptors.
R.J.M Bindels, A. Hartog and C.H. van Os, Department of Physiology,
University of Nijmegen, The Netherlands. Active transcellular Ca24 trans-
port in the rabbit kidney collecting system has been shown to be inhibited
by pharmacological activation of protein kinase C (PKC). Until now, a
physiological agonist of this regulatory pathway has not been identified.
Therefore, the role of extracellular ATP in regulating transcellular Ca2
transport as possible activator of PKC was investigated. Cells from the
rabbit cortical collecting system were isolated by immunodissection with
Mab R2G9 and subsequently cultured on permeable filters or on glass
coverslips to determine transcellular Ca24 transport and intracellular
Ca24 concentration ([Ca24]1), respectively. ATP (10—v to 1O M) reduced
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active transcellular Ca2 transport dose-dependently (IC50 = 3 /LM), with
a maximal inhibition of 43%. At 10 M, ADP had no effect on
transcellular Ca2 transport. On the contrary, AMP and adenosine
stimulated Ca2 transport rate by 118 3% (P < 0.05). This order of
potency suggests that ATP-induced inhibition is mediated by P2 purinergic
receptors. At the cellular level, ATP (10—v to i03 M) caused a rapid
transient increase in [Ca2]1 which returned to a slightly elevated sustained
level. The peak value of the [Ca2] transient increased dose-dependently
with an apparent Kd of 1 pM ATP, In the absence of extracellular Ca2,
a similar Ca2 peak was induced by ATP indicative for Ca2 release from
intracellular stores, but the sustained response was abolished. Loading the
cells with the Ca2 chelator BAPTA completely prevented the ATP-
induced Ca2 transients, without diminishing the inhibition of transcellu-
lar Ca2 transport. The protein kinase C activator, diacylglycerol (DAG),
mimicked the inhibitory effect of ATP on transcellular Ca2 transport. In
conclusion, extracellular ATP presumably binds to P2 receptors which
leads to activation of phospholipase C. Only activation of PKC by DAG
results in inhibition of transcellular Ca2 transport, while the 1P3-induced
Ca2 release and activation of a Ca2 entry mechanism does not affect
transcellular Ca2 transport.
Cardiac renin is kidney-derived. A.H.J. Danser, P.J.J. Admiraal, F.H.M
Derkx, J.MJ. Lamers, PD. Verdouw, P.R. Saxena, and M.A.D.H. Schale-
kamp, Depts. of Pharmacology, Biochemistry and Internal Medicine I and
Thoraxcenter, Erasmus University, Rotterdam, The Netherlands. The heart is
capable of generating and releasing angiotensin I (Ang I) and II (Mg II),
at least when renin is present in the coronary circulation. We measured
tissue levels of renin (R), angiotensinogen (Aogen), Mg I and Mg II in
left and right atrium and ventricle of hearts obtained from normal and
nephrectomized pigs (body weight 25—30 kg) within 2—3 minutes after
death. Cardiac tissue was homogenized, and both cytosol and membrane
fractions were prepared. Measurements of renin were made in the
presence and absence of the specific renin inhibitor Ro 42,5892 in order to
correct for Mg I generating activity not due to renin. Mg I and Mg II
were measured in cardiac homogenates after SepPak extraction and
HPLC separation. Cardiac renin (range 1.4—12 pmol Mg hg per hour),
Aogen (range 27.4—125 pmol/g), Mg I (range 5.7—48 fmol/g), and Mg II
(range 8.7—193 fmol/g) levels in normal pigs were all considerably higher
(2—10 fold) than could be explained by contamination with plasma. The
cardiac Mg Il/Ms I ratio was 2—3 times higher than in plasma. Cardiac
R, Mg I and Mg II were positively correlated and there was a direct
correlation between cardiac and plasma R levels. At least 15—20% of
cardiac R was membrane-bound and could only be solubilized by the
addition of 1% Triton X-100. Renin, Mg I and Mg H, but not Aogen,
were undetectable in both plasma and cardiac tissue obtained from
nephrectomized animals 30 hours post-nephrectomy. These results sup-
port existing evidence for the presence of angiotensin production in
cardiac tissue. Renin of renal origin is the most important, if not only, Ang
I generating enzyme in the heart. Part of this renin seems to be
membrane-bound.
Decreased production of heparan sulfate proteoglycan by cultured
human glomerular visceral epithelial cells and human mesangial cells
under hyperglycemic conditions. N.F, van Det, N.A.M Verhagen, J. T.
Tamsma, .1. van der Born, J.H.M. Berden, M.R. Daha, J.A. Bn4jn, and F.J.
van der Woude, Depts. of Endocrinology, Pathology and Nephrology, Uni-
versity Hospitals Nijmegen and Leiden, Nijmegen and Leiden, The Nether-
lands. Recently, we have demonstrated a decrease in heparan sulfate
glycosaminoglycan (HS-GAG) staining in the glomerular basement mem-
brane of diabetic kidneys. To study the mechanism underlying this
phenomenon we cultured human glomerular visceral epithelial cells
(GVEC) and human mesangial cells (MC) under normal and hyperglyce-
mic conditions. 35S sodium sulfate (100 /.LC1/ml) and 3H glucosamine (25
rCi/ml) were used for proteoglycan labeling. Experiments were per-
formed under normal (5 mi glucose) and hyperglycemic (25 mii glucose)
conditions. Proteoglycans were isolated after two DEAE chromatography
purification steps. The content of each peak was analyzed by sensitivity to
nitrous acid, chondroitinase ABC and AC on 050 Sephadex column
fractionation. Heparan sulfate was also detected by a sensitive inhibition
ELISA using mouse anti-GBM HS-GAG side chain specific antibodies.
The majority of macromolecular 35S sulfate and 3H GAG from the
HPLC-DEAE column eluted as two partially separated peaks. Peak I
contained HSPG and reacted positive in the HS-GAG ELISA for both
AMC and GVEC. Peak II from AMC contained dermatan sulphate
proteoglycan (DSPG) and from GVEC a mixture of HSPG and chon-
droitin sulfate proteoglycan(CSPG). We observed a decrease in 3H
HSPG/DSPG ratio when MC and GVEC were grown under hyperglyce-
mic condition. ELISA measurements in culture media revealed that high
glucose levels decrease HS production by both GVEC (0.31 g/ml/105
cells vs. 0.21/l0) and MC (0.433/10 vs. 0.244/10; P  0.05). In conclu-
sion: GVEC and MC produce less HS-GAG under hyperglycemic condi-
tions. This may explain the decreased HS-GAG staining in vivo observed
in kidneys with diabetic nephropathy. A decrease in glomerular HSPG
content could theoretically lead to albuminuria and mesangial cell expan-
sion.
Rapid onset of impaired afferent arteriolar (AA) responsiveness to
pressure and angiotensin II (Aug II) in rats with experimental diabetes
mellitus. P.M. ter Wee, H. Forster, and M. Epstein, Department of Nephrol-
ogy, Free University Hospita4 Amsterdam, The Netherlands, and Nephrology
Section VA Medical Center and University of Miami, Miami, Florida, USA.
Previous studies from our laboratory have demonstrated impaired AA
responsiveness to pressure in rats 6 weeks after induction of diabetes
mellitus. How rapidly this impairment in autoregulation ensues is contro-
versial. In order to further characterize the temporal profile of the
impairment in AA responsiveness, pressure-induced AA vasoconstriction
was examined in isolated perfused hydronephrotic kidneys from 1-week
diabetic rats (STZ; 55 mg/kg iv). In 8 rats, diabetes was left untreated
(DM). In 9 rats, insulin therapy (NOVO ultralente) was initiated the day
after the administration of STZ in order to achieve strict metabolic control
(DM+ Ins). Hydronephrosis of the right kidney was induced 4—6 weeks
prior to the perfusion study to permit videoinicroscopy of renal microves-
sels. Myogenic responsiveness was assessed by stepwise increments in
renal arterial pressure (RAP; 80 to 180mm Hg). Subsequently, Mg 11(3.0
X i0'° M) was added to the perfusate. Vessel diameters were measured
by computer-assisted image processing. As RAP was increased, AA from
the normal kidneys constricted markedly (17.1 1% diameter decrement
at 180 mm Hg; N = 35;P < 0.001 vs. 80 mm Hg), whereas AA from DM
kidneys manifested attenuated constrictions (8.7 2%; N = 37;P < 0.005
vs. 80 mm Hg; P < 0.001 vs. control). Insulin treatment prevented the
impairment in AA responsiveness to pressure (18.1 1.6%; diameter
decrement at 180 mm Hg; N = 34; P < 0.001 vs. 80 mm Hg; P < 0.001 vs.
DM). Mg Il-induced AA constrictor responses of DM kidneys was
reduced as compared to control rats (23.1 2.7% vs. 41.0 3.2%
diameter decrement, respectively; P < 0.005). DM + Ins AA manifested
constriction of 33.4 2.6% to Mg II (P < 0.01 vs. DM; NS vs. control).
We conclude that an impairment of AA responsiveness to pressure and
Mg II occurs early in the course of experimental diabetes mellitus which
can be prevented by insulin treatment.
Effect of atrial natriuretic peptide on renal and vascular permeability
in diabetes mellitus. R. Zietse, F.H. Derkx W. Weimar, and MA Sc/sale-
kamp, Dept. of Internal Medicine I, University Hospital Dijkzigt, Rotterdam,
The Netherlands. Synthetic human AN? (102—126) 0.01 g/kg/min or
vehicle was intravenously infused for 2 hours in 10 patients with insulin
dependent diabetes mellitus and microalbuminuria (albumin excretion
20—200 tg/min) and in 10 control subjects. In the diabetic group, the IgG
clearance was higher but both size- and charge-index as calculated from
albumin and immunoglobulin clearances were equal compared to con-
trols. The fractional clearances of small dextrans (<36 A) were lower in
diabetics, which was compatible with a depressed hydraulic permeability
(K1). During ANP infusion the excretion of albumin and IgG increased in
the diabetic subjects (189 12 to 521 84 .rg/min, and 7.1 3.5 to 21
8.1 jsg/min, respectively; both P < 0.05) but not in the controls. In the
diabetics the clearance of dextrans > 54 A increased and our calculations
indicated an increase in "shunt-flow" (e). The transcapillary escape rate
of albumin, which was elevated in the diabetics at baseline, increased in
the diabetic group only. Thus, ANP uncovers altered size-selectivity of the
filtration barrier in a phase that is otherwise characterized by charge-
selective changes only. Moreover, the increased susceptibility of the
glomerular capillaries in diabetics to AN? seems to be part of a more
generalized capillary abnormality, because AN? also increases the trans-
capillary escape of albumin.
Indirect measurement of lymphatic absorption using intraperitoneally
administered Inulin. T. Rowshanz, D.G. Strujk, G.C.M. Koomen, A.L.T.
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Imholz, and R. T. Krediet, Academic Medical Center, Amsterdam, The
Netherlands. The disappearance rate of intraperitoneally (i.p.) adminis-
tered macromolecules can be used as an indirect measurement of the fluid
loss from the peritoneal cavity by lymphatic absorption (LA) in CAPD
patients. The clearance (C) of i.p. solutes out of the peritoneal cavity is 1—2
mllmin larger than the appearance rate in the dialysate after intravenous
administration, irrespective of solute size. This difference can be used to
estimate LA rate (LAR). As a power relationship is present between the
mass transfer area coefficient (MTC) of small solutes or C of macromol-
ecules and their free diffusion coefficient in water, the theoretical C-inulin
from the circulation to the dialysate can be interpolated from the
MTC-creatinine and C-I32microglobulin using the free diffusion coefficient
of inulin (theoretical C-inulin). The difference between C-inulin after i.p.
administration (C-inulin observed) and theoretical C-inulin (inulin differ-
ence), can be used to represent LAR. Fluid and solute kinetics were
examined 42 times in 34 stable CAPD patients using 4-hour dwell,
dialysate glucose 1.36% to which dextran 70 1 g/liter and inulin 2.5 gfliter
were added. Mean duration of CAPD treatment was 28 months. LAR was
calculated as the dextran disappearance rate (DDR; standard method)
and also as the inulin difference (C-inulin). DDR was 1.22 0.08 ml/min
(mean SCM) and the C-inulin was 1.66 0.09 ml/min. A good
correlation was found between DDR and the zC-inulin: r = 0.60, P <
0.001. Both DDR and the zC-inulin were related to net ultrafiltration:
DDR: r =
—0.63, P < 0.001; 1C-inulin: r = —0.57, P < 0.001. It can be
concluded that the C-inulin can be used to estimate LAR in CAPD
patients. It also gives additional evidence that DDR is not caused by local
accumulation within the peritoneal cavity. LA proved to be an important
determinant of net ultrafiltration, irrespective whether DDR or AC-inulin
was used.
Value of the low-dose desferrioxamine (DFO) test in the diagnosis of
aluminum-related bone disease (ARBD) in dialysis (D) patients. P.C.
D'Haese, MM Couttenye, L.V. Lamberts, W.G. Goodman, G.D. Nuyts, E.
Lemoniatou, P. Digenis, I. Sotornilç, A. Fagalde, and M.E. De Broe, Depts.
of Nephrology, University of Antwerp, Belgium, UCLA, Los Angeles, Cali-
fornia, USA, Athens, Greece, Prague, Czech Republic, and Cordoba, Argen-
tina. The use of low DFO doses (5 mg/kg) provides an effective and safe
treatment of Al overload, raising the question of their diagnostic value as
well. In 73 D patients, histological and histochemical (AluminonR stain)
data and Al bulk analysis of bone biopsies were correlated with the results
of aS mg/kg DFO test. ARBD was defined as follows: positive Aluminon
stain (> 0%) with or without increased bone Al (> 15 g/g) combined
with histological features of either adynamic bone disease, mixed disease,
osteomalacia and normal histology with a bone formation rate < 250
jsm2/mm2/day. The test was considered positive when the post-DFO serum
Al increment was above 50 jsg/liter and iPTH < 350 ng/liter. Following the
above criteria, 31 out of the 73 D patients presented with ARBD. The
sensitivity (Se), specificity (Sp) and positive predictive value (PPV) of the
5 mg/kg DFO test were 78, 88, and 83%, respectively. By increasing the
iPTH threshold value up to 650 ng/liter, the Se increased up to 94%
whereas the Sp decreased to 76%. We conclude that the low DFO test in
combination with iPTH determination is a reliable test in the detection of
ARBD and accurately predicts the absence of the disease.
A frameshift mutation in the type IV collagen a3 gene in autosomal
recessive Alport syndrome. H. Lemmink, L. van den Heuvel, L. Kluzjtmans,
T. Mochizuk4 S. Reeders, L. Monnens, C. SchrOder, H. Brunner, and H.
Smeets, Departments of Human Genetics and Pediatrics, University Hospital,
Ntjmegen, The Netherlands; Boyer Center for Molecular Medicine, Yale
University School of Medicine, New Haven, Connecticut, USA. Alport
syndrome is a progressive hereditary glonierulonephritis with a heteroge-
neous clinical picture. In the majority of families the disease segregates
with markers from the Xq22 region, and in 9 of our group of 45 unrelated
patients, mutations were identified in the X-linked type IV collagen aS
gene (COI.4A5). As yet, 30% of the coding sequence has been analyzed.
Still, a number of families exists with no apparent X-linked inheritance,
and autosomal dominant or recessive inheritance should be considered. In
a Dutch family with two affected siblings, a boy and a girl, results of an
intragenic CA-repeat marker excluded the involvement of COIAA5. The
girl had severe symptoms of Alport syndrome (progressive renal failure
and hearing loss) and she reached end-stage renal disease at the age of 9
years. A kidney transplantation failed, because the child developed
progressive anti-glomerular basement membrane (anti-GBM) nephritis
against the allograft 6 months after transplantation. Her younger brother
suffered from hematuria and hearing loss as well, but his kidneys still
functioned normally at the age of 13 years. Their parents were unaffected.
Segregation of an intragenic CA-repeat marker was consistent with a
possible involvement of the COL4A3 gene, which is located on chromo-
some 2. Mutation analysis revealed that both patients were homozygous
for a 5 bp deletion in the fifth exon of the COL4A3 gene (counting from
the 3' end). The deletion disrupted the reading frame and introduced a
premature stop codon. It should produce a truncated protein without a
functional NC-domain. A competitive ELISA using the anti-GBM serum
confirmed the involvement of the COL.4A3 NC domain. In this case the
genetic defect explained the target of the antiserum.
Familial gloinerulonephritis characterized by massive deposits of fi.
bronectin: An uncommon cause of' nephrotic syndrome. KJ.M Assmann,
R.A.P. Koene, and J.F.M Wetzels, Depts of Pathology and Nephrology,
University Hospital Nijmegen, Nijmegen, The Netherlands. In 1985 a 40 year
old male patient was referred to our clinic because of proteinuria, which
was first discovered in 1976, and had increased to nephrotic range over the
last year. Serum creatinine was 79 smol/liter, albumin 27 g/liter and
urinary protein excretion averaged 6.4 g/24 hr. In serum no cryoglobulins
or paraproteins were found. Light microscopy (LM) of a renal biopsy
showed enlarged glomeruli with massive deposits of a homogeneous,
eosinophilic material in the subendothelial areas and in the mesangium, in
which an increased number of mesangial cells were dispersed. The GBM
of the glomerular capillaries that were displaced to the periphery was
normal. Staining for amyloid was negative. The deposits only stained
faintly for immunoglobulins (heavy and light chains), complement factors
Clq and C3, and the extracellular matrix proteins collagen IV and laminin
in the immunofluorescence (IF). However, they strongly stained with mAb
against fibronectin. By electron microscopy, massive deposits with a fine
granular appearance were seen in the mesangium and frequently in the
subendothelial spaces. By higher magnification these deposits appeared to
be composed of irregularly arranged fibrils of 10—12 sm in diameter,
suggestive for fibronectin. Surprisingly, no fusion of epithelial foot pro-
cesses or influx of inflammatory cells were seen. Nephrotic range protein-
uria persisted over the next eight years; however, renal function remained
stable. A second biopsy taken eight years later demonstrated similar
lesions, with hardly any progression by LM. Recently, a 21 year old son
also underwent a kidney biopsy because of a moderate proteinuria. LM
showed identical lesions to the biopsy of his father. Using mAb specific for
cell-derived fibronectin (IST-9) and plasma and cell-derived fibronectin
(IST-4), we could additionally demonstrate that the fibronectin deposited
in the glomeruli was derived from the plasma. In conclusion, we present a
rare form of familial glomerulonephritis (GN) that is characterized by
massive deposits of fibrillar arranged fibronectin without any inflamma-
tory response. This GN has an indolent course with hardly any deteriora-
tion of renal function.
Rapid inactivation of C5b-9 by vitronectin and CDS9, but not CDSS
determines the rat strain-dependent development of proteinuria in anti-
Thy-i nephritis. D. Salazar, MR. Daha, A.v.d. Wal, J.A. Bnsijn, PhJ.
Hoedemaeker, W. G. Couser, and E. De Heer, Depts. of Pathology and
Nephrology, University of Leiden, Leiden, The Netherlands, and University of
Washington, Seattle, Washington, USA. Injection of rats with anti-Thy-i
antibodies results in the rapid development of proteinuria in Wistar, BN,
AO and F344 rats (max. at day 3), but no proteinuria in PVG and MAXX
rats. Genetic studies with MHC-congenic strains revealed that the ob-
served strain differences were governed by non-MHC genes. We then
investigated whether differences in the possible inactivation of C5b-9
complexes by complement inhibitors were responsible for these differ-
ences in proteinuria development. Irrespective of the development of
proteinuria in all rat strains, we observed an increasing mesangial expres-
sion of CD55 (DAF) within 24 hours after injection of ER4. Double label
IF with 0X7 (IgGi anti-Thy-i) demonstrated an exclusive expression of
CD55 on mesangial cells. Mesangial CD55 expression was shown to
colocalize with C5b-9 complexes as detected by a monoclonal antibody
against rat C5b-9 neoantigen. In non-proteinuric strains C5b-9 complexes
persisted in the mesangial area for at least 7 days and they immediately
(within 1 hr) colocalized with vitronectin and CD59 (HRF-20, 4 hrs).
However, in proteinuric rats C5b-9 complexes were removed within 6 days
from the mesangial area. In these rats mesangial colocalization with either
vitronectin, or CD59, could not be observed. Pretreatment of PVG rats
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with antibodies against either vitronectin or CD59, followed by adminis-
tration of anti-Thy-i antibodies, resulted in immediate development of
proteinuria. This study shows that the susceptibility of complement-
mediated damage in the glomerulus may be related to genetic differences
in its capability to inactivate Cb5-9 complexes by complement inhibitors.
Albuminuria in the heterologous phase of anti-GBM nephritis in beige
mice is not mediated by platelets or fibrin. G. W. Feith, KJ.M Assmann,
Mu. T Boginan, A.P.M. van Gompel, J. Schalkwijjk, and RAP. Koene,
Depts. of Pathology, Dennatology, and Nephrology, University Hospital
Nijmegen, Nijmegen, The Netherlands. Beige mice, which are deficient for
leukocytic neutral proteinases, do not develop albuminuria within 24
hours after injection of rabbit anti-mouse GBM Ig (RaMGBM). After 24
hours, however, a gradually increasing albuminuria is observed which is
maximal at day 5. Albuminuria is preceded by an influx of PMN in the
glomeruli and progressive intravascular coagulation. Therefore, we have
now studied the role of platelets and fibrin in the development of the
albuminuria in the late heterologous phase of passive anti-GBM nephritis
in beige mice, Platelet depletion was induced and maintained by repeated
i.p. administration of rabbit anti-mouse platelet Ig (mean platelet count
throughout the entire experimental period 17 x 109/liter vs. 395 ><
109/liter, P < 0.002). Controls were treated with normal rabbit 1g. PMN
influx in the glomeruli 2 hours after the induction of the nephritis was
comparable in both groups (4.1 0.4 PMN/glomerular cross section vs.
5.2 1.3 in the control group). On day 3 after the i.v. injection of
RaMGBM, neither albuminuria [10301 6067 g/18 hr (N = 8) in the
experimental group vs. 7835 6320 g/i8 hr (N = 11) in controls] nor the
extent of the glomerular damage as assessed by light microscopy, were
influenced by the thrombocytopenia. By immunofluorescence (IF), fibrin
deposits were present in comparable amounts in both groups. Fibrinogen
depletion by the administration of Ancrod (blood fibrinogen <120
mg/liter in Ancrod treated mice vs. 2131 601 mg/liter in untreated
controls) also did not alter the extent of the albuminuria (12256 9697
ag/18 hr vs. 7443 5365 j.Lg/18 hr) nor the histological changes. In both
groups fibrin deposits could be detected in comparable amounts by IF.
Ultrastructurally, however, fibrin was not deposited as polymerized fibrin
in the Ancrod treated group. We conclude that neither platelets nor fibrin
are important mediators of the glomerular damage and the albuminuria
occurring in the late heterologous phase after the injection of RaMGBM
in beige mice.
Molecular construction of glomerular sclerotic lesions in experimental
immune complex nephritis. E.C. Bergzjk J.J. Baelde, E. de Heer, P.D.
Killen, andf.A. Bruijn, Dep:s. of Pathology, University of Leiden, Leiden, The
Netherlands, and University of Michigan, Ann Arbor, Michigan, USA.
Induction of chronic serum sickness by repetitive injections of human IgG
into preimmunized Wistar rats leads to the development of immune
complex nephritis of which glomerulosclerosis is a severe complication.
The aim of this study was to elucidate the role of the extracellular matrix
(ECM) in the development of glomeruloscierosis in this model. Protein-
uria increased when injection of human IgO had been started. Injections
were stopped when the rats had developed proteinuria exceeding 800
mg/24 hr. This moment was considered week 0. At this early stage
fibrinogen accumulation was observed along the endothelial cells, proba-
bly related to damage of the endothelial lining. mRNA levels for several
collagen types, laminin Bi and B2, and fibronectin (fn) were significantly
increased in both whole-kidney tissue and in isolated glomeruli, but
morphological changes were not observed. In situ hybridization experi-
ments demonstrated increased ECM mRNA levels in glomerular and
tubular cells. Starting at week 15, glomerular mesangial matrix expansion
and thickening of the glomerular basement membrane (GBM) were
observed. Several ECM components, including laminin, fn, and collagen
types IV, and VI, were abundantly present. Coagulation factors were not
observed at this moment. ECM mRNA levels were decreased as compared
to week 0, but were still above normal, Focal and segmental end-stage
sclerotic lesions developed at weeks 25—30. Fn and fibrinogen were the
major constituents of these lesions. Other ECM components were found
peripherally from these lesions in the remnants of the mesangial matrix
and GBM. Sclerotic matrices did not demonstrate an increase of cellular-
fn, and other constituents from the circulation were not present in the
lesions. Glomerular ECM mRNA was decreased to normal levels. How-
ever, a dramatic increase of fn and al(IV)col mRNA expression was
observed at sites of inflammatory infiltrate in the perivascular, interstitial,
and periglomerular regions. These facts, together with accumulation
studies, strongly suggest that in the final stage of chronic serum sickness
there is a specific accumulation of exogenous fn in the end-stage sclerotic
lesions in glomeruli, and that simultaneously an interstitial inflammatory
reaction takes place leading to increased ECM production in the tissue
surrounding the damaged glomeruli.
Changes in the glomerular filtration barrier induced by contact be-
tween a human plasma factor and kidney tissue. P.K Cheung A. Boes,
W. W. Bakker, Department of Pathology, University of Groningen, Gmningen,
The Netherlands. The pathogenesis of minimal change nephrotic syndrome
(MCNS) is largely unknown. Several circulating factors have been sus-
pected to play a role in the pathogenesis of MCNS; however, a causal
relationship between the activity of such factors and the glomerular lesion
is lacking. Previously, we have described a heat labile vasoactive factor in
normal human plasma (100 kF, molecular wt 100 kD) which is able to
induce glomerular alterations in the rat kidney characteristic for MCNS,
such as diminished subendothelial heparan sulphate proteoglycans, an-
ionic sites, and reduction of glomerular sialoglycoproteins (GSP). In
addition it was shown that in plasma of subjects with MCNS during
relapse, lOOkF in activated form was detected. Since we recently also
observed reduced stainability for glomerular ectonucleotidase (ATP/
ADPase) in biopsies from subjects with MCNS (in contrast to other forms
of glomerulopathy), the question emerged whether lOOkF is able to induce
this effect. Therefore, partially purified lOOkF solutions [6.0mg protein in
4.0 ml phosphate buffered saline (PBS) pH 7.4 at 37°C] was perfused for
6 minutes into the left kidneys of anesthetized Wistar rats (N = 6) ex vivo
according to standard methods. Contralateral kidneys were treated iden-
tically with heat-inactivated (HI) lOOkF. Cryostate sections of both
kidneys were stained for GSP using colloidal iron, and for ATP/ADPase
activity using standard enzyme histochemistry. These stainings were also
done using: (a) rat (N = 8) and human kidney sections (N = 5), and (b)
confluent human endothelial cell cultures (N = 6), following in vitro
incubation with either lOOkF in various concentrations (0.5; 1.0; 1.5; 2.0
and 2.5 mg/mI PBS) or HI material for 2.0 hours at 37°C. The results show
a significant reduction of stainability for GSP and glomerular ATP/
ADPase after lOOkF perfusion, while in vitro incubation with lOOkF of rat
and human kidney sections showed similar results in a dose-dependent
manner. Also, in human endothelial cell cultures a significant dose
dependent decrease of stainability for GSP and ectonucleotidase could be
detected following lOOkF incubation. It is concluded that lOOkF is able to
affect glomerular and endothelial GSP as well as ectonucleotidase. Since
biopsies from subjects with MCNS show decreased GSP and a diminished
number of subendothelial anionic sites, whereas ectonucleotidase (in the
rat kidney predominantly located along the subendothelial part of the
GBM) is also injured by this factor, we feel that lOOkF activated in vivo
may affect the endothelial and subendotheial part of the glomerular
filtration bather in subjects with MCNS.
Apoptosis during and after regeneration from gentamicin toxicity in the
rat kidney. E.J. Nouwen, M.Q. Zhu, and ME. De Broe, Dept. of Nephrology,
University of Antwerp, Antwerp, Belgium. Female Wister rats (200—250 g)
were s.c. injected 3 times daily with gentamicin (400 mg/kg/day) during 2
days and were sacrificed at regular time intervals over a period of 10 days.
During this period acute tubular necrosis confined to the proximal tubules,
followed by regeneration, could be observed. The occurrence of apoptosis
or programmed cell death was quantitated in cortical proximal and distal
tubules during injury and regeneration. Apoptosis, which was absent in
controls, was rare in the injured and regenerating PCT before day 10:
approximately one apoptotic cell was seen in every 10 tubular cross-
sections. However, during the development of severe proximal tubular
necrosis, apoptosis started to occur in cortical distal tubules at day 1,
reached a peak at day 2, and gradually declined thereafter. It parallelled
the increased proliferative activity in the distal tubules in this period.
Upon completion of morphological recovery of the PC'l' at day 10, this
segment had become hyperplastic, and a 5-fold increase in apoptosis was
observed. In conclusion: (1) Apoptosis in morphologically undamaged
distal tubules could be the consequence of tubular obstruction during the
first days after induction of acute renal failure; (2) The enhanced
occurrence of apoptosis in the PCT early after completion of regeneration
may provide a mechanism to normalize the excess in cell number.
Differential binding of PR3 and MPO to monolayers of RUVEC. ANCA
mediated ADCC of PR3/MPO incubated HUVEC? B.E.P.B. Bal1ieux K
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Zondervan, P. Kievit, E.G. Hagen, F.J. van der Woude, L.A. van Es, and
MR. Daha, Dept. of Nephrology, University Hospital Leiden, Leiden, The
Netherlands. Introduction: Binding of both PR3 and MPO to endothelial
cells (EC) has been suggested to be involved in the vascular damage seen
in patients with Wegener's Granulomatosis or microscopic poliangiitis.
ADCC and complement or neutrophil mediated mechanisms in the
presence of anti-neutrophil cytoplasmic antibodies (ANCA) have been
proposed. We investigated in detail the interaction of MPO and PR3 with
cultured human EC and its matrix products. We also performed ADCC
experiments on PR3/MPO incubated HUVEC monolayers after interac-
tion with ANCA positive sera or rabbit anti-PR3/MPO. Methods: ELISA's
were performed with PR3 coated onto monolayers of HUVEC and rabbit
IgG directed against PR3. MPO was coated under similar conditions onto
monolayers of HUVEC and directly detected using a peroxidase substrate
(ABTS). Before adding the substrate in some experiments the endothelial
cells were detached from the extracellular matrix with PBS/EDTA and the
substrate was added separately to the cells and to the remaining matrix.
For ADCC, 51Cr labeled monolayers of HUVEC were coated with
PR3IMPO, incubated with anti-PR3/MPO and incubated for 6 hours with
PBMC. Results: Both MPO and PR3 strongly bind to cultures of HUVEC.
Separation of the endothelial cells and the extracellular matrix before
adding the substrate showed binding of MPO both to the cells and to the
matrix. PR3 only bound to the matrix. Bound MPO could not be detected
by anti-MPO. No ADCC reactivity mediated by anti-PR3IMPO was found
against PR3/MPO coated HUVEC monolayers. Discussion: The results
described above show differences in the binding properties of MPO and
PR3 to EC. In contrast to MPO, PR3 binds mainly to the extracellular
matrix, possibly explaining the lack of anti-PR3 mediated ADCC. MPO is
probably bound to cryptic sites out of reach for anti-MPO antibodies.
Differential vascular endothelial expression of adhesion molecules in a
rabbit model of granulomatous vasculitis. J. W. Cohen Ters'aert, MI.
Cybuisky, MA. Gimbrone, Jr., Vascular Research Division, Dept. of Pathol-
ogy, Brigham and Women's Hospital Boston, Massachusetts, USA. Granu-
lomatous vasculitis, characterized by angiocentric mononuclear leukocyte
accumulation, can be induced by intravenous injection of f3-glucan parti-
cles (S. cerevisiae) in rabbits, as previously described in rats. In this study,
we studied endothelial-dependent mechanisms during development of
pulmonary lesions. New Zealand white rabbits (1.5—2 kg) were injected
with 15 mg/kg p-glucan and sacrificed at different time intervals. Immu-
nohistochemical staining was performed on frozen sections with Mab
Rbl/9 (VCAM-1), 14G2 (E-selectin), and Rb 2/3 (ICAM-1). Northern
blot analysis of RNA extracted from lungs was done with rabbit VCAM-i,
ICAM-1, E-selectin, interleukin-8 (IL-8), and monocyte chemoattractant
protein-i (MCP-1) cDNA probes. Immediately after glucan injection,
embolization with glucan aggregates was found in small pulmonary
vessels. At 4 hours, a localized, inflammatory response around glucan
aggregates in the lumen of these vessels was found. VCAM-1 and ICAM-1
staining was diffusely and markedly increased in vessels with and without
emboli, whereas E-selectin was only focally and minimally expressed in a
few vessels. At 24 hours, mural vasculitis with destruction of vessel walls
was detected. Many glucan particles were at least partly extravascularly
localized, surrounded by monocytes and macrophages. Endothelial ex-
pression of VCAM-1 and ICAM-i was markedly increased, whereas
E-selectin was absent. At 4—5 days, there were well-demarcated interstitial
granulomas and virtually all glucan particles were now found extravascu-
larly, engulfed by macrophages. Endothelial ICAM-1 and VCAM-1
staining was reduced to nearly normal levels and E-selectin was absent. At
4 hours, a clear increase in VCAM-1, ICAM-i, IL-8 and MCP-i mRNA
expression was observed, whereas no increase in E-selectin mRNA
expression was found. At 24 hours, mRNA for IL-8 was still increased,
whereas mRNA levels of VCAM-1, ICAM-1, E-selectin, and MCP-1 were
comparable to those found in control rabbits. This model may be useful
for the further analysis of molecular regulatory mechanisms responsible
for the differential regulation of endothelial-dependent processes in an
integrative pathophysiological setting.
Hypertriglyceridemia in nephrotic syndrome is only partially due to
increased hepatic fatty acid (FA) synthesis and triglyceride secretion. J.A.
Joles, C. Bijleveld, A. van To!, MJ.H. Geelen, and HA. Koomans, Nephrol-
ogy, Medical Faculty and Biochemists'y, Veterans Faculty, Utrecht; Biochem-
istiy, Erasmus University, Rotterdam, The Netherlands. Hepatic cholesterol
synthesis and secretion are stimulated by low plasma oncotic pressure (ir)
in nephrotic syndrome (NS) causing hypercholesterolemia. On the other
hand, hypertriglyceridemia has been associated with delayed catabolism of
triglyceride (Tg)-rich particles. It is unknown whether hepatic FA synthe-
sis and Tg secretion are also stimulated by decreased IT. Thus, we
measured activity of 2 key enzymes of FA synthesis in hepatic cytosol:
acetyl CoA carboxylase (ACC) and FA synthase (FAS) from control
(CON) male Sprague-Dawley (SD) rats, and rats with either congenital
analbuminemia (NAR) or SD rats with adriamycin-induced NS. In a
second cohort we measured post-Triton Tg secretion rates (TgSR;
nmol .min1), assuming a plasma volume of 4% body weight (body wt).
CON NAR NS
N 10 7 9
Proteinuna mg .d'
Plasma IT mm Hg
Plasma apo BAU
30 4
18.3 0.7
88 10
14 2
13.2 O.3
168 8
811 45'
10.7 0.4'
285 35w'
ACC/gbodywt 100±6 145±iia 139±i5a
% of CON
FAS/gbodywt 100±5 165±19a 215±31a
% of CON
N 10 6 9
Plasma Tg mmol . l'
TgSR nmol min'
0.51 0.05
0.52 0.03
2.13 0.16a
0.69 0.06a
3.38 047ab
0.69 0.05a
a P < 0.05vs. CON; bP < 0.05 vs. NAR; Abbreviation AU is arbitrary
units.
In conclusion, hepatic FA synthesis capacity, monitored by ACC and FAS,
as well as TgSR, were increased in rats with low ir. In addition, however,
neither FA synthesis nor TgSR was higher in NS rats than in NAR,
although IT was lower in NS rats than in NAR. Therefore, higher Tg levels
in NS rats, as compared to NAR, are probably due to a proteinuria-related
disturbance in Tg catabolism.
Renin-inhibition restores pressure natriuresis (PN) in essential hyper-
tension (EH). P. van Paassen, G.J. Navis, P.E. de Jon& and D. de Zeeuw,
University Hospital Groningen, The Netherlands. One of the features of EH
is an abnormal PN. Experimental evidence suggests a mechanistic role for
the renin-angiotensin system (RAS). We tested this hypothesis by mea-
suring PN relations and PRA in 7 hospitalized ambulant EH patients both
before and after one week treatment with the specific renin-inhibitor
Remikiren (Rem, 600 mg oral compound, at noon). Patients were on a
diet containing 50 mmol Na, 100 mmol K and 2500 ml fluid. PN was
evaluated by correlating the daily fluctuations in ambulatory blood
pressure (every 15 minutes, Spacelabs) and UNa (every two hours), both
over a period of 48 hours. Before Rem, mean arterial pressure (MAP) was
109.4 1.2mm Hg and 94.8 1.3 during day and night, respectively; UNa
was 38.5 3.2 mmol/24 hrs and PEA (12.00 hr) was 2.7 0.4
nmol/liter/hr. During Rem, an accumulated Na loss of 68 (—25 to 200)
mmol occurred. When sodium excretion had stabilized at 39.2 3.1
mmol/24 hrs, MAP was 100.1 1.2 and 89.7 1.3 mm Hg during day and
night, respectively, and PRA was 1.1 0.1 nmolJliter/hr at trough. The
mean changes in MAP and UNa did not correlate (r = 0.31, NS) before
Rem, whereas the PN relation was restored after Rem treatment (r = 0.66,
P <0.01). Indeed, individual patients showing a poor PN relation showed
a restoration of PN upon treatment, whereas the PN relation improved in
those with an already significant PN relation before treatment (P < 0.02).
Interestingly, the presence or absence of a significant PN relation before
treatment was explained by the initial PRA (higher PEA values corre-
sponded with poorer PN relation; r = 0.78, P < 0.05). Moreover, the
treatment induced change in PN correlated with the decrease in PRA (r =
0.81, P < 0.05). In conclusion, the RAS plays an important role in the PN
defect, since interference in the RAS with a specific renin-inhibitor
restores this defect.
The acute effects of ACE-inhibition (ACE1) on hippuran (Hip) handling
in normal and adriamycin (ADR) nephrotic rats. W.D. K!oppenburg G.J.
Navis, P.E. de Jon& and D. de Zeeuw, State University Hospital Groningen,
The Netherlands. Kidney diseases and vasoactive drugs can reduce the
renal extraction of Hip (EHip), affecting the reliability of this tracer to
estimate renal plasma flow (RPF). The effect of ADR nephropathy on
EHip and the acute effect of ACEi on Hip handling in nephrosis has never
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been investigated. We, therefore, studied EHip in normal (C, N = 11) and
nephrotic male Wistar rats, on a low sodium intake, before and after
ACEi. Nephrosis was induced by a single injection of ADR (2.5 mg/kg),
resulting in a stable proteinuria of 466 62 and 659 68 mg/24 hr at 4
weeks (Al, N = 10) and 12 weeks (A2, N = 8), respectively. Clearances
and extraction ratios of the tracers '311-Hip and 'I-Iothalamate, mean
arterial pressure (MAP) and urine volume (UV) were measured before
and after lisinopril (10 mg/kg i.v.) under halothane anesthesia. Baseline
measurements and changes after ACEi are listed in the table.
EHip
£ ratio %
ERPF RPF GFR MAP
mm Hg
UV
pJ/30 mmml/min/100 g body wt
C 0.75 0.02 2.49 0.12 3.35 0.21 0.75 0.04 93 3 360 19
Al 0.72 o.or 2.20 0.09 3.10 0.15 0.65 0.OV 97 2 397 26
A2 0.73 0.01 1.88 0.14a 2.59 0.17 0.53 0.05a 102 V 417 49
% change from baseline after ACEi
C
Al
A2
—11 3ab
9s 15..6b ...224b
19±4ab 35 5" —l
17±3'" 2l5" 3±4a
....344b
—20 3 12±13'
22±9'
Data are mean SaM. 'P < 0.05 vs. C; ,P < 0.05 vs. baseline. Wilcoxon
2-sided analysis.
The EHip, although aumerically lower, was well preserved in ADR rats,
despite renal function impairment. ACEi induced a fall in EHip in normal
and ADR rats. The changes varied considerably between the rats and were
more pronounced in normal rats. Combining all groups, the fall in EHip
correlated with the drop in MAP (r = 0.48, P C 0.001), UV (r = 0.61, P C
0.01), and GFR (r = 0.56, P C 0.01). In conclusion, in ADR rats the
reliability of clearance measurements to estimate RPF is similar as in
normal rats. After acute ACE no reliable RPF estimation can be made,
due to a fall in EHip. This fall in EHip was especially prominent when
pronounced decreases in GFR and UV occurred, probably due to a
decreased filtration pressure associated with a sharply decreased MAP in
these rats. The attenuated effects of ACEi in the nephrotic rats compared
to the normal rats suggest that the renin angiotensin system may be
suppressed in ADR nephrosis.
Assessment of renal viability before transplantation by 35P magnetic
resonance. R.J. Hen4 J. van der Grond, WP.Th.M. Mali, and HA.
Koomans, Depts. of Nephrology and Radiodiagnosis, Utrecht University
Hospital, Utrecht, The Netherlands. In 30% of all transplantations the
kidney shows a delayed function, whereas in about 5% the transplants will
never start functioning, mostly due to bad conditions before or during
preservation. These numbers will increase when kidneys of non-heart
beating donors (NHB) are being used. A non-invasive method to predict
renal viability before transplantation would therefore be very helpful. We
investigated the efficacy of 31P magnetic resonance spectroscopy (MRS), a
non-invasive technique of mapping phosphorus metabolism of intact
biological systems, performed during the preservation period, to predict
postoperative graft function. We performed 31P MRS on 42 human
transplant kidneys preserved in HTK solution (a preservation solution not
containing phosphate). Kidneys were derived from 33 donors: 5 living
related, 22 heart beating, and 6 NHB. The ratio of the phosphomonoester
peak (Pm), mainly composed of AMP, and the inorganic phosphate peak
(Pi) was used as a parameter for viability. In kidneys showing immediate
function after transplantation we found a relation between the Pm/Pi ratio
and the time between nephrectomy and MRS (r = —0.74, P C 0.0001,
slope —0.036). Using this equation the Pm/Pi value at nephrectomy and at
implantation could be extrapolated. Kidneys from non-heart beating
donors had, at nephrectomy, lower estimated Pm/Pi ratios than those of
heart beating donors (2.14 0.29 and 1,35 0.40, respectively). In the
NHB group and heart beating derived kidneys Pm/Pi ratios were lower in
those which showed delayed graft function (P C 0.05), when extrapolated
for nephreetomy as well implantation time. When 2 kidneys from the same
donor were measured, generally there was no difference in Pm/Pi ratio. In
4 cases, however, 1 kidney had a lower ratio than the other. In these cases
a delayed graft function occurred only in the kidneys with the lowest ratio.
This might suggest that preservation quality might differ even within
kidneys from the same donor. In conclusion, we showed that 31P MRS
may predict postoperative graft function. The sensitivity to predict delayed
graft function was 73%, specificity 84%, and efficacy 81%.
Simultaneous reduction of blood pressure and proteinuria by chronic
angiotensin converting enzyme (ACE)-inhibition in hypertensive fawn-
hooded (FHH) rats. A.P. Provoost, L. T Sterlç, G.H. Verseput, and J.J.
Weening, Erasmus University, Rotterdam, and AMC, Amsterdam, The
Netherlands. The FHH rat is a model for spontaneous focal glomerulo-
sclerosis (FGS), characterized by early systemic and glomerular hyperten-
sion and proteinuria (UpV). ACE-inhibition has been shown to be very
effective in the prevention of renal damage in various models of FGS.
However, the efficacy to reduce damage in rats with advanced renal
disease is not well-known. We tested the effects on SBP, UpV, FGS, and
glomerular volume (V0) of 4 ACE-inhibitors in 25 male, 6 month-old
FHH rats with established hypertension and UpV. Dosages per liter
drinking fluid were: lisinopril (L), 100 and 25 mg/liter; enalapril (E), 200
and 100 mg/liter; captopril (C), 600 and 200 mg/liter; fosinopril (F), 100
mg/liter. Treatment groups consisted of 3—6 rats. Results were compared
with those of 6 control (CON) FHH rats. During 15 weeks of treatment
SBP and UpV were determined every 3 weeks. After treatment the
incidence of FOS and V0 was assessed.
SBP0 SBP15
mmHg
UpV0 Up V15
mg/day
FUS
%
V0
CON 155 162±3 193 392±44 28±5 2.54±0.23
L-100 150 2 109 212 27 7 8 3 1.97
L-25 150±2 1o8±3a 232±34 67±17a 11±1 2.19±0.30
E-200 151±8 108±P 227±37 41±3a 5±2 2.57±014
E-100 168 3 124 3' 226 33 169 32 18±3 2.36 0.25
C-600 153 118±1' 232± 12 777a 10±6 2.31±0.21
C-200 162±4 139±3a 206±20 275 25±4 2.25
F-100 148±2 153±4 234±7 406±52 45 12 238±0.11
All data are mean SD; a P C 0.05 vs. CON; ANOVA.
Dose-dependent reductions in SBP and UpV were found for L, E, and C.
At the only dose used, F had no effect. Regression analysis showed a close
correlation between SBP and UpV during treatment. Furthermore, the
rise in UpV between 3 and 15 weeks correlated with the average SBP
during that period. At autopsy, the incidence of FOS was correlated with
final SBP and UpV. No significant correlation was found between V0 and
SBP, UpV, or FGS. In conclusion, in FHH rats with progressive renal
damage, chronic ACE-inhibition can effectively reduce SBP, UpV, and the
incidence of FOS without affecting in V0.
Vascular rejection (It) after kidney transplantation occurs early and
is a major determinant of both short-term and long-term survival.
J.L.C.M. van Saase, F.J. van der Wou4e, J. Thorogood, AA.M Hollander,
LA. van Es, and LA. Bru:Jn, Department of Nephrology, Leiden University
Hospital, and The Eurotransplant Foundation and University Dept of
Medical Statistics, Leiden, The Netherlands. Vascular rejection is thought to
be the major cause of graft loss after the first year after kidney transplan-
tation. To investigate the time of onset of vascular rejection we studied all
consecutive patients (N = 482) receiving a post-mortal kidney between
1983 and April 1991 in our center. We report findings from biopsies taken
during the first three months after transplantation and the consequences
for long-term graft survival and risk factors for developing a specific type
of rejection. Ninety-three patients lost their grafts due to rejection during
a 9-year follow-up period. One year graft survival was 88.9% for 241
patients without rejection, 87.4% for 111 patients with interstitial rejection
(IR), and 50% for 84 patients with VR. Five-year graft survival for these
groups was 74.4%, 72.1%, and 35.8%, respectively. The relative risk of
graft loss was 4.35 (95%, CI 2.89—6.55) for VR and 1.20 (95%, CI
0.75—1.92) for JR compared to patients without rejection during the first 3
months. Risks were calculated with the Cox proportional hazards regres-
sion model with VR and JR as time dependent co-variables. Yearly graft
loss due to chronic rejection was 2%/year in patients without early
rejection, 2.%5'ear in patients with IR, and 7.7% in patients with VR.
Major risk factors for developing vascular rejection were use of azathio-
prine without cyclosporin, number of HLA-DR mismatches, prolonged
cold isehemia time, and previous transplantations. Risk factors for IR
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were use of azathioprine without cyclosporin, recipient age and HLA-DR
mismatches. We conclude that VR occurs within a short time period
following renal transplantation (within 3 months), and is a very strong
predictor of graft loss while IR has a minor negative effect on graft
survival. HLA-DR mismatching is a strong risk factor for developing
rejection.
Conversion from cyclosporin (C5A) to azathioprine (Aza) after cadav-
eric kidney transplantation (KT): In the long run a better renal function,
less hypertension and equal graft survival. A.A.MJ. Ho/lander, J.L.C.M.
van Saase, A.MM Kootte, W. T. van Dorp, H.H. van Bockel, L.A. van Es,
and F.J. van der Woude, Dept. of Nephrology andDept. of Suigety, University
Hospital Leiden, Leiden, The Netherlands. In the period from 1983—1988,
128 patients who received a first or second cadaveric kidney graft
participated in 2 prospective, randomized trials in which CsA was either
continued or replaced by Aza at 3 months after KT. All patients received
high doses of CsA (16 mg/kg/day tapered to 10 mg/kg/day depending on
CsA blood levels) and low doses of prednisone (initial dose 20 mg/day
tapered to 10 mg/day). Three months after KT patients were randomly
assigned to continue CsA (N = 68) or were converted from CsA to Aza(N = 60). In the CsA group the drug dose was tapered to 5 mg/kg/day,
depending on CsA blood levels. In the converted group the prednisone
was temporarily increased to 25 or 40 mg/day and was tapered off to 10
mg/day. There were no differences between the two groups in age, sex,
number of KT, HLA mismatches, panel reactive antibodies, and cold and
warm ischemia time. The long-term follow-up (FU) of these patients
showed an equal mortality rate in both groups (CsA: 13.2% vs. Aza:
11.7%). Graft survival after 2, 5 and 8 years was 88.4%, 75.4%, and 66.5%
for CsA patients and 88.3%, 78.3%, and 76.3% for Aza patients (P =
0.53). Renal function was considerably better in the Aza group: after 1
year the mean creatinine clearance in the converted patients was 78
mI/mm versus 60 mI/mm in the CsA patients (difference 18 mI/mm; 95%
CI: 8.1—27.5). This difference remained the same during 8 years of FU.
Less proteinuria (> 0.5 g/day) was found in the Aza patients at 5 years
(30% vs. 48% in the C5A patients; P < 0.05). There was no difference in
blood pressure between the 2 groups before KT, at 3 months and during
FU, but CsA patients needed significantly more antihypertensive drugs:
after 2 years 87% versus 58% of Aza patients. This difference did not
change during FU. We conclude that elective conversion at 3 months
post-transplant can be done safely and that beneficial long-term effects
were found regarding graft survival, renal function, proteinuria, and
hypertension.
Modulating side effects of OKT3 by variation of the time point of
methylprednisolone (MPNS) administration: Postponement and put oIL
F.J. Bemelman, P. Th.A. Schellekens, S. Buysmann, F. van Diepen, S.
Surachno, and R.J.M ten Beige, Renal Transplant Unit and Department of
Clinical Immunology, Department of Internal Medicine, Academic Medical
Centre, University of Amsterdam, Amsterdam, The Netherlands. OKT3, a
murine IgG2a monoclonal antibody, used in prevention and treatment of
allograft rejection, induces severe clinical side effects, which are partly
cytokine-mediated. Cytokine release is mediated by OKT3 coated lym-
phocytes. Steroids induce lymphocytopenia with a nadir 6 hours following
administration. To diminish adverse reactions OKT3 is preceded by
MPNS. The aim of the study was to determine the optimal time interval
between MPNS and OKT3 administration. Three groups of renal trans-
plant patients (pts) treated for acute rejection with 5 mg OKT3 for ten
consecutive days were studied: 10 pts received 500 mg MPNS 6 hours
before OKT3 (—6 group); 10 pts received 500 mg MPNS 1 hour before
OKT3 (—1 group); and 6 pts received 250mg MPNS 6 and 1 hours before
OKT3 (—6/—i group). We measured: clinical side effects by a score
grading from ito 6; body temperature; TNF and IL-6 by ELISA. Values
are given as mean SEM, and a P value of 0.05 was considered significant.
Results: (1) Side effects score in the —6/—i group was significantly lower
compared to the —1 group and —6 group (1.0 0.25, 2.9 0,48 and 2.3
0.47, respectively; (2) Peak body temperature in the —6/—i group was
significantly decreased compared to the —1 group and —6 group (37.7
0.48°C, 38.8 0.16°C, and 39.4 0.2°C, respectively). Peak temperature
in the —6 group was postponed compared to the —1 and —6/—i group; (3)
Peak TNF levels were significantly increased in the —1 group compared to
the —6 group and the —6/—i group (1132 154 pg/mI, 553 138 pg/ml,
and 612 128 pg/mI, respectively); (4) Peak IL-6 levels were significantly
increased and postponed in the —6 hour group compared to the —1 and
—6/—i group (190 65 pg/mI 6 hrs following OKT3, 89 50 pg/mI and
29.1 16 pg/ml 3 hrs following OKT3, respectively). Conclusion: MPNS
should be administered 6 hours and 1 hour prior to OKT3.
Additive antiproteinuric effect of ACE inhibition (ACEi) and a low
protein diet (LPD) in human renal disease. R T. Gansevoort, D. de Zeeuw,
and FE. de Jon& University Hospital, Groningen, The Netherlands. Both
ACEi and LPD are reported to prevent progressive renal function decline.
The renoprotective effect of both regimens has been suggested to be partly
related to the proteinuria lowering effect. Whether the combination of
ACEi and LPD might have an additive value is unknown. We therefore
studied the antiproteinuric effect of ACEi, LPD, and their combination in
14 proteinuric patients with stable, non-diabetic renal disease. The
protocol consisted of two parallel studies, each of 4 periods. Measure-
ments took place at the end of each of the two months, lasting for the
study period. In part I, the additive effect of ACEi to LPD was investi-
gated. In part II, vice versa, the additive effect of LPD to ACEi was
investigated. Normal protein diet (NPD) was defined as 1.5 g protein/kg
body wt (when Ccr >70 mI/mm), or 1 g protein/kg body wt (when Ccr <70
ml/min), while LPD was defined as a 50% decrease in prescribed protein
intake during NPD. ACEi was achieved with enalapril 10 mg o.i.d.
Part I NPD LPD
LPD +
ACEi LPD
MAPmmHg 95±3 92±3 833ab 955
Uura mmol/24 hr
Uprot g/24 hr
411 59
7.5 0.9
212 20°
6.2 0.8°
230 24
3.5 07gb
228 25°
5.5 0.9
Part II NPD NPD +
ACEi
LPD +
ACEi
NPD +
ACEi
MAP mmHg
Ua mmol/24 hr
Uprot g/24 hr
102±5
415 67
14.0 2.1
90±4a
468 64
9.3 1.9°
92±6a
300 53b
6.9 1.7°"
92±4a
412 52
8.2 1.7
Data are mean SE. P < 0.05 vs. 1st; bP < 0.05 vs. 2nd study period
(ANOVA).
ACEi lowered Uprot with 45 6% during LPD, and with 33 9% during
NPD. LPD decreased Uprot substantially less, with 17 5% in patients
without ACEi, and with 23 7% in patients on ACEi. However, the
prescribed reduction in protein intake did not always reach the desired
goal, and since a correlation was found between the decrease in protein
intake and Uprot (r = 0.85, P < 0.001), this suggests that a greater
reduction in protein intake might result in a greater decrease in Upro,.
Interestingly, ACEi and LPD had an additive antiproteinuric effect, as
Uprot decreased with 51 5% on combined therapy. As a result of LPD
treatment GFR and ERPF decreased slightly, while serum albumin and
serum protein remained stable. During ACEi treatment GFR also de-
creased slightly, while serum albumin, serum protein and ERPF increased
significantly. In conclusion, both ACEi and LPD lower urinary protein
excretion. Moreover, these regimens have an additive antiproteinuric
effect. Whether this will result in an additive protective effect on the rate
of renal function decline has yet to be proven.
Chiorambucil is superior to pulse cyclophosphamide in the treatment
of patients with membranous nephropathy and deteriorating renal func-
tion. L.J.M. Reichert, RAP. Koene, J.F.M Wetzels, and The Study Group,
Dept. of Medicine, Div. of Nephrology, University Hospital Nijmegen, Nijme-
gen, The Netherlands. We examined whether immunosuppressive treat-
ment in patients with membranous nephropathy and deteriorating renal
function resulted in the preservation of renal function. In a prospective
randomized trial we compared chlorambucil (CH; 0.15 mg/kg/day orally,
months 2, 4 and 6) plus prednisone (P; 3 pulses methylprednisolone 1 g
i.v., followed by oral prednisone 0.5 mg/kg/day, months 1, 3 and 5) with i.v.
cyclophosphamide (CY; 750 mg/rn2, every month during 6 months) plus
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methyiprednisolone (M; 3 pulses of 1 g, months 1, 3 and 5). Eighteen
patients with idiopathic membranous nephropathy (17 males, 1 female), a
nephrotic syndrome (protein/creatinine index 9.1 3.8 so) and renal
insufficiency (serum creatinine  150 moI/liter) were studied, Before
treatment serum creatinine had increased from 146 69 to 260 112
mol/liter (P = 0.003) in the CH+P group and from 151 87 to 217
85 mol/liter (P = 0.016) in the CY ÷ M group. During the treatment
period serum creatinine decreased in the CR + P group from 260
mol/liter to 186 74 Mnlol/liter (P =0.003), and rose in the CY + M
group from 217 j.&mol/liter to 297 143 mol/liter (P = 0.02). The
difference between CH + P and CY + M was highly significant (P <
0.0005). Serum albumin rose in both groups by 9 and 6 g/liter, respectively,
and protein/creatinine ratio decreased by 2.5 and 3 glmmol, respectively.
At 12 months the difference in serum creatinine was sustained (CH + P
213 71 mol/liter, CY + M 596 391 molIliter). At the end of
follow-up (average 21 months, range 6—36 months) 1 patient in the CH +
P group had reached end-stage renal failure after 36 months, whereas in
the CY + M group 3 patients had reached ESRD after 12, 18 and 18
months, and 1 patient had died after 6 months. These results indicate that
combined treatment with chiorambucil plus prednisone is superior to i.v.
cyclophosphamide plus methylprednisolone in patients with membranous
nephropathy and deteriorating renal function.
